DDPH, a novel antihypertensive agent, is a potential dual inhibitor of hepatic CYP2D and CYP3A

Chemico-biological Interactions
Yinsong ZhuHui Chen

Abstract

DDPH (1-(2, 6-dimethylphenoxy)-2-(3, 4-dimethoxyphenylethylamino) propane hydrochloride) is a promising novel antihypertensive agent, with potent antihypertensive, neuroprotective and cardioprotective effects. This study aimed to investigate the effects of DDPH on the expression and activity of hepatic cytochrome P450 (CYP) isoforms and evaluate the metabolic drug-drug interactions of DDPH with propafenone. Our results showed that orally administered DDPH (12.5-50 mg/kg/d) for 7 days significantly inhibited CYP2D1 and CYP3A1 activity and mRNA and protein expression but weakly increased CYP1A2 activity and expression in rats. Enzyme kinetics studies showed that DDPH was a competitive inhibitor of CYP2D1 and mixed inhibitor of CYP3A1 in rat liver microsomes with Ki values of 3.70 ± 0.42 μM and 4.79 ± 1.10 μM respectively. With human liver microsomes, DDPH was a noncompetitive inhibitor of CYP2D6 (Ki = 0.85 ± 0.06 μM) and mixed inhibitor of CYP3A (Ki = 2.15 ± 0.41 μM). Further in vivo study showed that oral administration of DDPH (12.5-50 mg/kg/d) for 7 days in rats significantly increased the area under the plasma concentration-time curve (AUC) of propafenone by 25.4%-63.9%, with a concomitant decrease in the plasma clearance. In...Continue Reading

References

May 1, 1989·Pharmacology & Toxicology·J MäenpääO Pelkonen
Jul 1, 1997·Archives of Biochemistry and Biophysics·Z HuangL S Kaminsky
Feb 13, 2001·Antimicrobial Agents and Chemotherapy·Z DestaD A Flockhart
Jul 2, 2003·Pharmacogenomics·David F V Lewis
Jan 28, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ying-Hong WangStephen D Hall
Oct 14, 2004·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Minoo Afshar, Mohammadreza Rouini
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·Marcella MartignoniRuben de Kanter
Mar 17, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Gérard SiestSophie Visvikis-Siest
Jul 12, 2008·Archives of Toxicology·Olavi PelkonenHannu Raunio
Apr 9, 2009·Nature Reviews. Cardiology·Norman M Kaplan
Jul 30, 2009·Drug Discovery Today·Marcel J de GrootRuth Hyland
Mar 12, 2010·Journal of Clinical Pharmacology·Petra M JauslinMats O Karlsson
May 8, 2010·Current Drug Metabolism·Jing-Fang Wang, Kuo-Chen Chou
Jan 12, 2011·Biochemical Pharmacology·Su-Young ChoiHyunyoung Jeong
Apr 22, 2011·Journal of Clinical Pharmacology·Gilles E O'HaraJacques Turgeon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.